Permeability of human amniotic membrane to ofloxacin in vitro

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 2, 2010, Pages 1024-1027

  Resch, Miklós D ^a   Resch, Béla E ^b   Csizmazia, Eszter ^b   Imre, László ^a   Németh, János ^a   Révész, Piroska ^b   Csányi, Erzsébet ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

OFLOXACIN; ANTIINFECTIVE AGENT; EYE DROPS;

AMNION; ARTICLE; ARTIFICIAL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYOPRESERVATION; DRUG DETERMINATION; DRUG PENETRATION; DRUG RELEASE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; ULTRAVIOLET SPECTROPHOTOMETRY; DIFFUSION CHAMBER; METABOLISM; PERMEABILITY; TRANSPLANTATION;

AMNION; ANTI-BACTERIAL AGENTS; DIFFUSION CHAMBERS, CULTURE; HUMANS; OFLOXACIN; OPHTHALMIC SOLUTIONS; PERMEABILITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 77449098853     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4254     Document Type: Article

References (31)

1. von Versen-Hoynck F, Syring C, Bachmann S, Moller DE. The influence of different preservation and sterilisation steps on the histological properties of amnion allografts-light and scanning electron microscopic studies. Cell Tissue Bank. 2004;5:45-56.
2. Seitz B, Das S, Sauer R, Mena D, Hofmann-Rummelt C. Amniotic membrane transplantation for persistent corneal epithelial defects in eyes after penetrating keratoplasty. Eye. 2009;23:840-848.
3. Solomon A, Meller D, Prabhasawat P, et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology. 2002;109:694-703.
4. Takano Y, Fukagawa K, Miyake-Kashima M, et al. Dramatic healing of an allergic corneal ulcer persistent for 6 months by amniotic membrane patching in a patient with atopic keratoconjunctivitis: a case report. Cornea. 2004;23:723-725.
5. Meller D, Pires RT, Mack RJ, et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology. 2000; 107:980-989.
6. Solomon A, Pires RT, Tseng SC. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001;108:449-460.
7. Anderson DF, Prabhasawat P, Alfonso E, Tseng SC. Amniotic membrane transplantation after the primary surgical management of band keratopathy. Cornea. 2001;20:354-361.
8. Wang MX, Gray TB, Park WC, et al. Reduction in corneal haze and apoptosis by amniotic membrane matrix in excimer laser photoablation in rabbits. J Cataract Refract Surg. 2001;27:310-319.
9. Price FW Jr, Whitson WE, Gonzales J, et al. Corneal tissue levels of topically applied ofloxacin. J Cataract Refract Surg. 1997;23:898-902.
10. Healy DP, Holland EJ, Nordlund ML, et al. Concentrations of levofloxacin, ofloxacin, and ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration. Cornea. 2004;23:255-263.
11. Donnenfeld ED, Schrier A, Perry HD, et al. Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor. Ophthalmology. 1994;101:902-905.
12. Ross D, Riley CM. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int J Pharmaceutics. 1990;63: 237-250.
13. The Ofloxacin Study Group. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. Ophthalmology. 1997;104:1902-1909.
14. Eros I, Csoka I, Csanyi E, Takacs-Wormsdorff T. Examination of drug release from hydrogels. Polym Adv Technol. 2003;14:1-7.
15. Csoka I, Csanyi E, Zapantis G, et al. In vitro and in vivo percutaneous absorption of topical dosage forms: case studies. Int J Pharm. 2005;291:11-19.
16. Makai M, Csanyi E, Nemeth ZS, Palinkas J, Eros I. Structure and drug release of lamellar liquid crystals containing glycerol. Int J Pharm. 2003;256:95-107.
17. Beck R, van Keyserlingk J, Fischer U, Guthoff R, Drewelow B. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor using different topical application modes. Graefes Arch Clin Exp Ophthalmol. 1999;237:89-92.
18. Çekiç O, Batman C, Totan Y, et al. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration. Ophthalmic Surg Lasers. 1999;30:465-468.
19. von Keyserlingk J, Beck R, Fischer U, et al. Penetration of ciprofloxacin, norfloxacin and ofloxacin into the aqueous humour of patients by different topical application modes. Eur J Clin Pharmacol. 1997;53:251-255.
20. Ev Lda S, Schapoval EE. Microbiological assay for determination of ofloxacin injection. J Pharm Biomed Anal. 2002;27:91-96.
21. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release. 2001;73:205-211.
22. Fegade JD, Mehta HP, Chaudhari RY, Patil VR. Simultaneous spectrophotometric estimation of ofloxacin and ketorolac tromethamine in ophthalmic dosage form. Int J Chem Tech Res. 2009;1:189-194.
23. Espinosa-Mansilla A, Muñoz de la Peña A, Cañada-Cañada F, González Gómez D. Determinations of fluoroquinolones and nonsteroidal anti-inflammatory drugs in urine by extractive spectrophotometry and photoinduced spectrofluorimetry using multivariate calibration. Anal Biochem. 2005;347:275-286.
24. Chavanpatil M, Jain P, Chaudhari S, Shear R, Vavia P. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. Int J Pharm. 2005;304: 178-184.
25. Kovacs L, Gellen J, Falkay G. Amniotic chloride concentrations in twin-pregnancy after intra-amniotic injection of hypertonic saline. J Obstet Gynaecol Br Commonw. 1972;79:54-59.
26. Resch MD, Schlötzer-Schrehardt U, Hofmann-Rummelt C, Sauer R, Kruse FE, Seitz B. Adhesion structures of amniotic membranes integrated into human corneas. Invest Ophthalmol Vis Sci. 2006; 47:1853-1861.
27. Resch MD, Schlötzer-Schrehardt U, Hofmann-Rummelt C, et al. Integration patterns of cryopreserved amniotic membranes into the human cornea. Ophthalmology. 2006;113:1927-1935.
28. Kim HS, Sah WJ, Kim YJ, Kim JC, Hahn TW. Amniotic membrane, tear film, corneal, and aqueous levels of ofloxacin in rabbit eyes after amniotic membrane transplantation. Cornea. 2001;20:628-634.
29. Diamond JP, White L, Leeming JP, et al. Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol. 1995;79:606-609.
30. O'Brien TP, Sawusch MR, Dick JD, et al. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits. Arch Ophthalmol. 1988;106:1444-1446.
31. Robert PY, Adenis JP. Comparative review of topical ophthalmic antibacterial preparations. Drugs. 2001;61:175-185